Recent Quotes
My Watchlist
Indicators
OGJ 150 Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Immunis Inc.

News headline image
Immunis Named by The Healthcare Technology Report as One of the “Top 50 Healthcare Technology Companies of 2025”
From Immunis Inc.
Via Business Wire
News headline image
Immunis Honored with the National Academy of Medicine’s 2025 Healthy Longevity Catalyst Award
From Immunis Inc.
Via Business Wire
News headline image
Immunis Successfully Completes its Phase 1/2a Clinical Trial Targeting Muscle Atrophy
From Immunis Inc.
Via Business Wire
News headline image
Immunis Discusses with Experts Why the Immune System is the Key to Human Healthspan
From Immunis Inc.
Via Business Wire
News headline image
Immunis Publishes Research Showing Secretomes Improve Metabolism and Muscle While Reducing Fat in Aged Models
From Immunis Inc.
Via Business Wire
News headline image
Immunis Wins Corporate LiveWire’s 2023 “Innovation and Excellence Award”
From Immunis Inc.
Via Business Wire
News headline image
Immunis Chairman Dr. Hans Keirstead to Speak at the Ending Age-Related Diseases Summit
From Immunis Inc.
Via Business Wire
News headline image
Immunis Recruits Individuals with Muscle Atrophy for Phase 1/2a Clinical Trial
From Immunis Inc.
Via Business Wire
News headline image
Immunis Initiates Patient Enrollment for Muscle Atrophy Phase 1/2a Clinical Trial
From Immunis Inc.
Via Business Wire
News headline image
Immunis Signs Clinical Trial Agreement with CIRM Alpha Stem Cell Clinics
From Immunis Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>